122 related articles for article (PubMed ID: 11703617)
1. Role of contact system activation in hemodialyzer-induced thrombogenicity.
Frank RD; Weber J; Dresbach H; Thelen H; Weiss C; Floege J
Kidney Int; 2001 Nov; 60(5):1972-81. PubMed ID: 11703617
[TBL] [Abstract][Full Text] [Related]
2. A monoclonal antibody raised against human beta-factor XIIa which also recognizes alpha-factor XIIa but not factor XII or complexes of factor XIIa with C1 esterase inhibitor.
Esnouf MP; Burgess AI; Dodds AW; Sarphie AF; Miller GJ
Thromb Haemost; 2000 Jun; 83(6):874-81. PubMed ID: 10896241
[TBL] [Abstract][Full Text] [Related]
3. Activated human platelets induce factor XIIa-mediated contact activation.
Bäck J; Sanchez J; Elgue G; Ekdahl KN; Nilsson B
Biochem Biophys Res Commun; 2010 Jan; 391(1):11-7. PubMed ID: 19878657
[TBL] [Abstract][Full Text] [Related]
4. The AN69 ST haemodialysis membrane under conditions of two different extracorporeal circuit rinse protocols a comparison of thrombogenicity parameters.
Richtrova P; Opatrny K; Vit L; Sefrna F; Perlik R
Nephrol Dial Transplant; 2007 Oct; 22(10):2978-84. PubMed ID: 17597089
[TBL] [Abstract][Full Text] [Related]
5. Contact activation-induced complex formation between complement factor H and coagulation factor XIIa.
Thangaraj SS; Christiansen SH; Graversen JH; Sidelmann JJ; Hansen SWK; Bygum A; Gram JB; Palarasah Y
J Thromb Haemost; 2020 Apr; 18(4):876-884. PubMed ID: 31984663
[TBL] [Abstract][Full Text] [Related]
6. Distinctive regulation of contact activation by antithrombin and C1-inhibitor on activated platelets and material surfaces.
Bäck J; Lang MH; Elgue G; Kalbitz M; Sanchez J; Ekdahl KN; Nilsson B
Biomaterials; 2009 Dec; 30(34):6573-80. PubMed ID: 19783299
[TBL] [Abstract][Full Text] [Related]
7. Determination of contact phase activation by the measurement of the activity of supernatant and membrane surface-adsorbed factor XII (FXII): its relevance as a useful parameter for the in vitro assessment of haemodialysis membranes.
Matata BM; Courtney JM; Sundaram S; Wark S; Bowry SK; Vienken J; Lowe GD
J Biomed Mater Res; 1996 May; 31(1):63-70. PubMed ID: 8731150
[TBL] [Abstract][Full Text] [Related]
8. Reciprocal relationship between contact and complement system activation on artificial polymers exposed to whole human blood.
Huang S; Engberg AE; Jonsson N; Sandholm K; Nicholls IA; Mollnes TE; Fromell K; Nilsson B; Ekdahl KN
Biomaterials; 2016 Jan; 77():111-9. PubMed ID: 26584351
[TBL] [Abstract][Full Text] [Related]
9. Blood activation during neonatal extracorporeal life support.
Plötz FB; van Oeveren W; Bartlett RH; Wildevuur CR
J Thorac Cardiovasc Surg; 1993 May; 105(5):823-32. PubMed ID: 7683735
[TBL] [Abstract][Full Text] [Related]
10. Evidence of contact activation in patients suffering from ST-elevation myocardial infarction.
Christensen K; Kozarcanin H; Ekdahl KN; Nilsson B
Thromb Res; 2016 May; 141():158-62. PubMed ID: 27058272
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of three different methods to prevent dialyzer clotting without causing systemic anticoagulation effect.
Richtrova P; Rulcova K; Mares J; Reischig T
Artif Organs; 2011 Jan; 35(1):83-8. PubMed ID: 20626736
[TBL] [Abstract][Full Text] [Related]
12. Factor XII activation markers do not reflect FXII dependence of thrombin generation induced by polyvinylchloride.
Frank RD; Mueller U; Lanzmich R; Floege J
J Mater Sci Mater Med; 2013 Nov; 24(11):2561-6. PubMed ID: 23864336
[TBL] [Abstract][Full Text] [Related]
13. A nanobody-based method for tracking factor XII activation in plasma.
de Maat S; van Dooremalen S; de Groot PG; Maas C
Thromb Haemost; 2013 Sep; 110(3):458-68. PubMed ID: 23349032
[TBL] [Abstract][Full Text] [Related]
14. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion.
Wachtfogel YT; Kucich U; Hack CE; Gluszko P; Niewiarowski S; Colman RW; Edmunds LH
J Thorac Cardiovasc Surg; 1993 Jul; 106(1):1-9; discussion 9-10. PubMed ID: 7686593
[TBL] [Abstract][Full Text] [Related]
15. Measurement of activated factor XII in health and disease.
Coppola R; Cristilli P; Cugno M; Ariëns RA; Mari D; Mannucci PM
Blood Coagul Fibrinolysis; 1996 Jul; 7(5):530-5. PubMed ID: 8874863
[TBL] [Abstract][Full Text] [Related]
16. Thrombogenicity and long-term cytokine removal capability of a novel asymmetric triacetate membrane hemofilter.
Körtge A; Wild T; Heskamp B; Folk M; Mitzner S; Wasserkort R
J Artif Organs; 2018 Dec; 21(4):435-442. PubMed ID: 30039457
[TBL] [Abstract][Full Text] [Related]
17. Contact activation products are new potential biomarkers to evaluate the risk of thrombotic events in systemic lupus erythematosus.
Bäck J; Lood C; Bengtsson AA; Ekdahl KN; Nilsson B
Arthritis Res Ther; 2013; 15(6):R206. PubMed ID: 24299152
[TBL] [Abstract][Full Text] [Related]
18. Factor XIIa inhibition by Infestin-4: in vitro mode of action and in vivo antithrombotic benefit.
Xu Y; Cai TQ; Castriota G; Zhou Y; Hoos L; Jochnowitz N; Loewrigkeit C; Cook JA; Wickham A; Metzger JM; Ogletree ML; Seiffert DA; Chen Z
Thromb Haemost; 2014 Apr; 111(4):694-704. PubMed ID: 24336918
[TBL] [Abstract][Full Text] [Related]
19. Studies of adsorption, activation, and inhibition of factor XII on immobilized heparin.
Sanchez J; Elgue G; Riesenfeld J; Olsson P
Thromb Res; 1998 Jan; 89(1):41-50. PubMed ID: 9610759
[TBL] [Abstract][Full Text] [Related]
20. Activation of the contact system in patients with a first acute myocardial infarction.
Konings J; Govers-Riemslag JW; Spronk HM; Waltenberger JL; ten Cate H
Thromb Res; 2013 Jul; 132(1):138-42. PubMed ID: 23746628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
